President Robert Rosen sold 200,000 shares of Heron Therapeutics stock in a transaction on Thursday, April 21st. The stock was sold at an average price of $23.23, for a total value of $4,646,000.00. Following the sale, the president now directly owns 178,968 shares of the company’s stock, valued at $4,157,426.64.
At lease he can live off the $ while he looks for his next position.........but the sales team....freshen up your resume
Net income of Negative 33.45 million this period compared to a net income of Negative 31.24 million last period. This is a growth of Negative7.05% over the previous period. Losing money and momentum.
His Compensation....he should not be complaining Over 4 million this year Total Annual Compensation, USD 540,750 All Other, USD 3,578,580 Fiscal Year Total, USD 4,119,330
Heron's stock price has dropped 33% this year as the Sustol delay drags on. Investors are already discounting the drug's commercial potential. Rosen knows it is a loser
That's not correct. He didn't want to sell those shares. He HAD to. That's what was meant by "programmed sell"
He is a complete joke. Only cares about himself and terrible leader. I worked with him years ago and it seems like nothing has changed. Heron will not make it with Rob on board. He will be fired if his track record holds up.